Niagen Bioscience, Inc. (NAGE): Cash & Equivalents
$44.50M
As of 2024-12-31
+16.4%
3-year compound annual growth
+18.8%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $44.50M | +63.6% | 2025-03-04, Balance as of period end |
| 2023-12-31 | $27.20M | +34.0% | 2024-03-06, Balance as of period end |
| 2022-12-31 | $20.30M | -28.1% | 2023-03-08, Balance as of period end |
| 2021-12-31 | $28.22M | +69.0% | 2022-03-14, Balance as of period end |
| 2020-12-31 | $16.70M | -11.2% | 2022-03-14, Balance as of period end |
| 2019-12-31 | $18.81M | n/a | 2021-03-12, Balance as of period end |